<div id="readability-page-1"><div><p>Guobang Pharma Ltd. reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 4,469.88 million compared to CNY 4,418.15 million a year ago. Revenue was CNY 4,469.88 million compared to CNY 4,418.15 million a year ago.</p><p>Net income was CNY 670.24 million compared to CNY 578.88 million a year ago. Basic earnings per share from continuing operations was CNY 1.21 compared to CNY 1.04 a year ago. Diluted earnings per share from continuing operations was CNY 1.21 compared to CNY 1.04 a year ago.</p></div></div>

605507

<p>Guobang Pharma Ltd. reported its earnings for the nine months ending September 30, 2025. The company achieved sales of CNY 4,469.88 million, up from CNY 4,418.15 million the previous year. Net income rose to CNY 670.24 million from CNY 578.88 million year-over-year. Basic and diluted earnings per share from continuing operations both increased to CNY 1.21, compared to CNY 1.04 a year ago.</p>

Guobang Pharma Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025